Curable sexually transmitted infections among pregnant women attending antenatal care facilities in low- and middle-income countries between 2000 and 2022: A systematic review and meta-analysis.
2022
(2022).
Immunobridging single-dose HPV vaccine in Tanzanian girls (DoRIS trial) to Kenyan women in whom single-dose efficacy has been demonstrated (KEN SHE trials).
2022
(2022).
Memory B-cell responses to different HPV vaccine regimes: Results from a dose-reduction randomised open-label trial (DoRIS) among Tanzanian school girls up to thirty-six months post-vaccination.
2022
(2022).
Malaria infection and antibody responses to single-dose HPV vaccination: Results from a dose-reduction immunogenicity trial (the DoRIS trial) among Tanzanian school girls.
2022
(2022).
Prevalence of curable sexually transmitted and reproductive tract infections among pregnant women attending antenatal care in Nchelenge, Zambia.
2022
(2022).
Bacterial vaginosis among pregnant women attending antenatal care facilities in low- and middle-income countries between 2000 and 2020: A systematic review and meta-analysis.
2022
(2022).
2022
Journal of Global Health, (2022).12, 10.7189/jogh.12.04071.
2022
BMC public health, (2022).22 1 10.1186/s12889-022-13927-x.
2022
The Lancet HIV, (2022).9 9 10.1016/S2352-3018(22)00163-1.
2022
SSM - Qualitative Research in Health, (2022).2, 10.1016/j.ssmqr.2022.100159.
